Application of Biomarkers in NSCLC—From Screening to Diagnostics Through Therapeutic Follow-up

Session Format

Live Webinar

Session Type

Plenary Presentation

Topic Area

Lung Cancer

Session Date

October 20, 2020 2:30 PM - 3:30 PM

Description

Minimally invasive approaches to early diagnosis of non-small cell lung cancer (NSCLC) have progressed rapidly; however, intermediate and lower-risk pulmonary nodules frequently present a diagnostic dilemma, and after bronchoscopy are still often referred for more invasive sampling. Adjunctive biomarkers are poised to improve our diagnostic algorithm and several have been shown to reduce the need for unnecessary surgical biopsy. The number and variety of biomarkers under active investigation merits a basic understanding of the biology and specific clinical application of the major available platforms.

Learning Objective 1

Review major classifications and basic biology of biomarkers in clinical use and under investigation to support early diagnosis and ongoing follow-up of NSCLC, to establish a framework for understanding their real-world utility.

Learning Objective 2

Discuss the utility of clinically available airway epithelial and serum biomarkers to help guide management of patients with solitary pulmonary nodules.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	1 CME Credit